Other popular GLP-1 drugs include: Originally developed to reduce blood glucose in type 2 diabetes only, research published in the New England Journal of Medicine in 2021 documenting the powerful weight loss effects of the active ingredient semaglutide began the movement to prescribe GLP-1 receptor agonists as an off-label weight-loss drug
DOI: 10.1002/mnfr.202100071 Liu, D., Alkhalidy, H., et al
10.1016/j.mito.2016.06.007 124 YuberoD.O'callaghanM.MonteroR.OrmazabalA.ArmstrongJ.EspinosC.et al
[DOI] [PubMed] [Google Scholar] 136.de Sousa Gonalves R., de Pinho F.A., Dinis-Oliveira R.J., Mendes M.O., de Andrade T.S., da Silva Solc M., Larangeira D.F., Silvestre R., Barrouin-Melo S.M
A 2025 meta-analysis of randomized controlled trials on moringa, published in MDPI Nutrients and conducted with a literature search through April 2025, found positive signals across glycemic and lipid parameters while acknowledging that larger, longer trials are needed
